Eargo 6 vs Otofonix Groove

The Eargo 6 is a premium-priced OTC hearing aid ($2,250) that earned a B grade and a SoundScore of 3.4/5 in our lab testing, placing it in the top 63% of OTC hearing aids we've evaluated. This invisible-in-ear device delivers solid speech clarity in quiet environments, scoring 3.3/5—notably 0.53 points above the OTC category average. Own-voice comfort is also above average at 2.9/5, though mixed in absolute terms. However, the Eargo 6 shows significant weaknesses in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, falling 0.48 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our testing—substantially below the category average. Feedback handling scored 3.3/5, solid in absolute terms but 1.24 points below the OTC average of 4.54/5. The device uses rechargeable batteries and maintains a fully invisible profile when worn. The Eargo 6 may suit consumers who prioritize discreet aesthetics and primarily need help hearing conversations in quieter settings. However, shoppers should note that alternatives like the Sony CRE-C10 and Olive Union Air achieved higher SoundScores at lower price points. Those frequently in noisy environments or who value music streaming should explore other options.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.